References
- Castleman B, Iverson L, Menendez V. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822–830. doi:10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4
- Chavez-Alvarez S, Villarreal-Martinez A, Ocampo-Candiani J, et al. Cutaneous manifestations of Castleman disease. Int J Dermatol. 2020;59(10):1226–1240. doi:10.1111/ijd.15043
- Wu D, Lim M, Jaffe E. Pathology of Castleman disease. Hematol Oncol Clin North Am. 2018;32(1):37–52. doi:10.1016/j.hoc.2017.09.004
- Fajgenbaum D, Uldrick T, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646–1657. doi:10.1182/blood-2016-10-746933
- Kim HJ, Han JH, Bang CH, et al. Cutaneous disorders associated with Castleman’s disease. Acta Derm Venereol. 2019;99(11):984–989. doi:10.2340/00015555-3253
- Dispenzieri A, Fajgenbaum D. Overview of Castleman disease. Blood. 2020;135(16):1353–1364. doi:10.1182/blood.2019000931
- Okuyama R, Harigae H, Moriya T, et al. Indurated nodules and plaques showing a dense plasma cell infiltrate as a cutaneous manifestation of Castleman’s disease. Br J Dermatol. 2007;156(1):174–176. doi:10.1111/j.1365-2133.2006.07577.x
- Khosroshahi A, Stone J. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):57–66. doi:10.1097/BOR.0b013e3283418057
- Deshpande V, Zen Y, Chan J, et al. Consensus statement on the pathology of IgG4-related disease. Mod pathol. 2012;25(9):1181–1192. doi:10.1038/modpathol.2012.72
- Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.3109/s10165-011-0571-z
- van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115–2124. doi:10.1182/blood-2018-07-862334